Matinas BioPharma Holdings (MTNB) Net Income towards Common Stockholders (QoQ) (2014 - 2026)
Matinas BioPharma Holdings (MTNB) Net Income towards Common Stockholders (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Matinas BioPharma Holdings | 4.60 Mn | 2.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.47% |
| Dec 31, 2025 | 11.07% |
| Sep 30, 2025 | -17.04% |
| Jun 30, 2025 | -10.93% |
| Mar 31, 2025 | 80.36% |
| Dec 31, 2024 | -97.26% |
| Sep 30, 2024 | 26.79% |
| Jun 30, 2024 | 1.07% |
| Mar 31, 2024 | -0.25% |
| Dec 31, 2023 | 4.03% |
| Sep 30, 2023 | 0.41% |
| Jun 30, 2023 | -10.26% |
| Mar 31, 2023 | -53.69% |
| Dec 31, 2022 | 33.45% |
| Sep 30, 2022 | 7.78% |
| Jun 30, 2022 | 0.93% |
| Mar 31, 2022 | 10.76% |
| Dec 31, 2021 | 2.01% |
| Sep 30, 2021 | -37.39% |
| Jun 30, 2021 | 3.70% |